Quantcast

J&J Recalls Tylenol Due To Moldy Odor

June 29, 2011

Johnson & Johnson announced another Tylenol recall due to a musty moldy odor linked to the trace chemical TBA.

The company’s McNeil Consumer Healthcare unit is recalling 60,912 bottles of Tylenol Extra Strength Caplets made in February 2009 and distributed in the U.S.

The chemical is a byproduct of a chemical preservative used on some shipping pallets.  TBA (2,4,6-tribromoanisole) has been associated with temporary and non-serious gastrointestinal symptoms.

J&J has had about two dozen recalls of prescription and nonprescription medicines, replacement hips, contact lenses and diabetes test strips since September 2009.

J&J pulled 40,000 bottles of Risperdal, a schizophrenia drug, on June 17 because of the chemical’s musty odor, which also led the company to recall shipments of the HIV drug Prezista and the seizure medicine Topamax this year.

The company said “this voluntary action is being taken as a precaution and the risk of serious adverse medical events is remote.”

J&J said this recall is being conducted with the knowledge of the U.S. Food and Drug Administration (FDA).

On the Net:




comments powered by Disqus